NM_001093.4:c.-10+3688T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001093.4(ACACB):c.-10+3688T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.121 in 152,118 control chromosomes in the GnomAD database, including 1,792 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1792 hom., cov: 32)
Consequence
ACACB
NM_001093.4 intron
NM_001093.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.195
Publications
5 publications found
Genes affected
ACACB (HGNC:85): (acetyl-CoA carboxylase beta) Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine-palmitoyl-CoA transferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis. [provided by RefSeq, Oct 2022]
UNG (HGNC:12572): (uracil DNA glycosylase) This gene encodes one of several uracil-DNA glycosylases. One important function of uracil-DNA glycosylases is to prevent mutagenesis by eliminating uracil from DNA molecules by cleaving the N-glycosylic bond and initiating the base-excision repair (BER) pathway. Uracil bases occur from cytosine deamination or misincorporation of dUMP residues. Alternative promoter usage and splicing of this gene leads to two different isoforms: the mitochondrial UNG1 and the nuclear UNG2. The UNG2 term was used as a previous symbol for the CCNO gene (GeneID 10309), which has been confused with this gene, in the literature and some databases. [provided by RefSeq, Nov 2010]
UNG Gene-Disease associations (from GenCC):
- hyper-IgM syndrome type 5Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.264 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACACB | ENST00000338432.12 | c.-10+3688T>C | intron_variant | Intron 1 of 52 | 1 | NM_001093.4 | ENSP00000341044.7 | |||
| UNG | ENST00000699563.1 | c.775-5553T>C | intron_variant | Intron 5 of 5 | ENSP00000514437.1 | |||||
| ENSG00000256139 | ENST00000541704.2 | n.577-4869T>C | intron_variant | Intron 2 of 2 | 5 | |||||
| ENSG00000256139 | ENST00000755021.1 | n.486-3482T>C | intron_variant | Intron 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.121 AC: 18358AN: 152000Hom.: 1788 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
18358
AN:
152000
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.121 AC: 18387AN: 152118Hom.: 1792 Cov.: 32 AF XY: 0.118 AC XY: 8752AN XY: 74364 show subpopulations
GnomAD4 genome
AF:
AC:
18387
AN:
152118
Hom.:
Cov.:
32
AF XY:
AC XY:
8752
AN XY:
74364
show subpopulations
African (AFR)
AF:
AC:
11095
AN:
41430
American (AMR)
AF:
AC:
1013
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
212
AN:
3470
East Asian (EAS)
AF:
AC:
332
AN:
5176
South Asian (SAS)
AF:
AC:
445
AN:
4820
European-Finnish (FIN)
AF:
AC:
621
AN:
10612
Middle Eastern (MID)
AF:
AC:
12
AN:
292
European-Non Finnish (NFE)
AF:
AC:
4395
AN:
68004
Other (OTH)
AF:
AC:
217
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
752
1504
2257
3009
3761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
194
388
582
776
970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
308
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.